[ Price : $8.95]
Consumer advocacy group Public Citizen urges Pfizer to commit to maintaining access to its medicines in Europe after comments by C...[ Price : $8.95]
Roche reports that its investigational breast cancer drug giredestrant failed to significantly extend progression-free survival in...[ Price : $8.95]
FDA says it recently held a meeting with several states to discuss implementation of a program that would allow the importation of...[ Price : $8.95]
Xenon Pharmaceuticals says its experimental epilepsy drug azetukalner met the primary endpoint in a late-stage clinical trial in p...[ Price : $8.95]
Ipsen voluntarily withdraws Tazverik (tazemetostat) from the market based on emerging data from the ongoing Phase 1b/3 SYMPHONY-1 ...[ Price : $8.95]
FDA investigators cite manufacturing and documentation issues at an Indian sterile drug facility operated by Maiva Pharma Private ...[ Price : $8.95]
A new national survey sees Americans expressing significantly greater confidence in FDA career scientists than in the leaders who ...[ Price : $8.95]
HHS says CBER director Vinay Prasad will step down at the end of April.